Excitatory actions of NMDA receptor antagonists in rat entorhinal cortex and cultured entorhinal cortical neurons.
J Väisänen, A M Lindén, M Lakso, G Wong, U Heinemann, E Castrén
Neuropsychopharmacology July 1, 1999 DOI: 10.1016/s0893-133x(99)00006-8 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Rat entorhinal cortex and cultured primary entorhinal cortical neurons |
| Interventions | MK-801 PCP ketamine |
| Key findings | NMDA receptor antagonists MK-801, PCP, and ketamine produce a strong, dose-dependent increase in c-fos expression in layer III of the rat caudal entorhinal cortex, which is inhibited by antipsychotic drugs. |
Abstract
We have characterized excitatory effects of non-competitive NMDA receptor antagonists MK-801, PCP, and ketamine in the rat entorhinal cortex and in cultured primary entorhinal cortical neurons using expression of immediate early gene c-fos as an indicator. NMDA receptor antagonists produced a strong and dose-dependent increase in c-fos mRNA and protein expression confined to neurons in the layer III of the caudal entorhinal cortex. Induction of c-fos mRNA is delayed and it is inhibited by antipsychotic drugs. Cultured entorhinal neurons are killed by high doses of MK-801 and PCP but c-fos expression is not induced in these neurons indicating that this in vitro model does not fully replicate the in vivo effects of PCP-like drugs in the entorhinal cortex. Excitatory effects of the NMDA receptor antagonists may be connected with the psychotropic side effects of these drugs and might become a useful model system to investigate neurobiology of psychosis.
Citations in the library
Cited by 4
- Ketamine evoked disruption of entorhinal and hippocampal spatial maps bioRxiv Preprint Server February 5, 2023
- NMDA receptor antagonist induced c-Fos expression in the medial entorhinal cortex during postnatal development. Frontiers in Neural Circuits 2025
- Ketamine administration reduced conditioned defensive behaviour and upregulated protein expression associated with neuroplasticity in a planarian model of aversive memory reactivation. Progress in neuro-psychopharmacology & biological psychiatry October 17, 2026
- Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia. Hippocampus 2001
Cites 7
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Recent advances in the phencyclidine model of schizophrenia American Journal of Psychiatry October 1, 1991
- NMDA Antagonist Neurotoxicity: Mechanism and Prevention Science December 6, 1991
- Cerebellar toxicity of phencyclidine Journal of Neuroscience March 1, 1995
- Effects of phencyclidine on immediate early gene expression in the brain. Journal of Neuroscience Research July 1, 1996
and 2 more in the library